clinical trial · NCT06712563
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
AstraZeneca·—·recruiting·n = 2,000
Pulmonary Disease, Chronic ObstructiveBudesonide/glycopyrrolate/formoterol fumarate
brief summary
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
started
Apr 17, 2025
primary completion
Dec 14, 2026
completion
Dec 14, 2026
last updated
Apr 21, 2026
official title
Pooled Analysis of Multi-country, Open-label Single-arm, Non-interventional, Multi-center, Cohort Studies of Real-world Outcomes in New Users of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol